Pharmafile Logo
Pharmafocus logo
Advanced Search

EU

Showing 15 posts of 252 posts found.

Bristol-Myers Squibb’s Yervoy scores EU approval in paediatric melanoma

January 23, 2018
Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, EU, Yervoy, pharma

Bristol-Myers Squibb has revealed that its immunotherapy Yervoy (ipilimumab) has received an expanded indication from the European Commission, approving the …

News
pixabay_puzzle-268905_640

European biotechs outperform US for investment return, report claims

November 29, 2017
Medical Communications, Sales and Marketing EU, Europe, US, investment, pharma

A new report from RSA Group has revealed that European biotech companies are “significantly outperforming” their US counterparts in terms …

News
bi_german_building_at_night

Boehringer celebrates EU approval of Humira biosimilar

November 14, 2017
Manufacturing and Production, Sales and Marketing Boehringer, Boehringer Ingelheim, Cyltezo, EU, Europe, European Commission, Humira, biosimilar

Boehringer Ingelheim has announced that Cyltezo, its biosimilar of Abbvie’s Humira, has received marketing authorisation approval from the European Commission, …

News
roche

Roche’s Tecentriq scores approvals in metastatic lung and bladder cancer

September 27, 2017
Research and Development, Sales and Marketing Cancer, EMA, EU, European Commission, Roche, bladder cancer, immunotherapy, lung cancer, pharma, tecentriq

It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …

News
novartis_side_building

Novartis scores EU approval in acute myeloid leukaemia and advanced systemic mastocytosis

September 20, 2017
Research and Development, Sales and Marketing EU, Europe, Novartis, acute myeloid leukaemia, advanced systemic mastocytosis, pharma, pharmaceutical

Novartis has announced that its targeted therapy Rydapt (midostaurin) has received EU approval in the two rare cancer indications: newly …

News
595427

Leo Pharma gets European approval for unique plaque psoriasis drug

July 20, 2017
Sales and Marketing EU, European Commission, biotech, drugs, pharma, pharmaceutical, psoriasis

The European Commission has announced that it has decided to approve Leo Pharma’s Kyntheum (brodalumab), making it the first and …

News
brexit-referendum-uk-1468255193y2p

What pharma should know about the European Unitary Patent in light of Brexit

July 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, biotech, brexit, drugs, healthcare, pharma, pharmaceutical

The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …

Feature
brexit

UK and EU life sciences demand closer collaboration in joint letter to Brexit negotiators

July 13, 2017
Sales and Marketing EU, UK, biotech, brexit, drugs, life sciences, pharma, pharmacuetical

The pharmaceutical and life sciences industries have stressed the importance of cooperation between the EU and the UK in order …

News
astrazeneca_sign_sky

New Pfizer EU approval offers first treatment option for leukaemia subtype

July 3, 2017
Sales and Marketing AstraZeneca, Besponsa, EU, European Commission

Pfizer has revealed that its drug Besponsa (inotuzumab ozogamicin) has received approval from the European Commission as a monotherapy for …

News

Novo Nordisk’s diabetes drug recommended for expanded indication in Europe

June 27, 2017
Research and Development, Sales and Marketing CHMP, EMA, EU, Novo Nordisk, Victoza

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to expand the indication of Novo …

News

PrimeVigilance is committed to minimising the impact of UK’s Withdrawal from the EU

June 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, primevigilance

Guildford, UK 14th  June, 2017

News
Press release
europe-1395916_640

New game, new rules: Pathways for better and affordable medicines in Europe

June 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …

Feature
astrazeneca_building_white

AZ’s Tagrisso continues successes with EU approval

April 26, 2017
Research and Development, Sales and Marketing AstraZeneca, EU, European Commission, NSCLC, Tagrisso

More good news for AstraZeneca’s Tagrisso (osimertinib), as the company announces that the European Commission has granted the drug full …

News
shutterstock_36423250

Trials and Tribulations: The impact of new clinical trial regulation in Europe

April 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, clinical trials, regulations

The clinical trial is the fulcrum on which drug development and treatment hinges. Even with the advent of new technologies …

Feature
charity_gifts_for_children_with_cancer_foundation_vanessa_isabel

Looming Brexit sparks fears for child cancer trials, experts warn

March 9, 2017
Medical Communications, Research and Development EU, ICR, brexit

The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025